4-Diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate
| Names | |
|---|---|
| IUPAC name
 Cytidine 5′-(1-deoxy-2-C-methyl-2-O-phosphono-D-erythritol-1-yl dihydrogen diphosophate)  | |
| Systematic IUPAC name
 O1-{[(2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxyoxan-2-yl]methyl} O3-[(2R,3S)-2,4-dihydroxy-3-methyl-3-(phosphonooxy)butyl] dihydrogen diphosphate  | |
| Identifiers | |
3D model (JSmol)  | 
|
| 8528909 | |
| ChEBI | |
| ChemSpider | |
| DrugBank | |
| KEGG | |
| MeSH | 4-diphosphocytidyl-2C+methylerythritol+2-phosphate | 
PubChem CID  | 
|
CompTox Dashboard (EPA)  | 
|
  | |
  | |
| Properties | |
| C14H26N3O17P3 | |
| Molar mass | 601.29 g/mol | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
4-Diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (or CDP-MEP, 4-diphosphocytidyl-2C methylerythritol 2-phosphate) is an intermediate in the MEP pathway of isoprenoid precursor biosynthesis.
It is formed by CDP-ME kinase (IspE) and is a substrate for 2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (IspF).